8.57

0.00% +0.00

Cryo Cell International Inc (CCEL)

Overview News Price History Financials Discussions Forecast Dividend History

Cryo Cell International Inc stock is currently priced at $8.57, with a 24-hour trading volume of 21,386. It has seen a +0.00% increased in the last 24 hours and a +13.36% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $8.47 pivot point. If it approaches the $8.69 resistance level, significant changes may occur.

Previous Close:

$8.57

Open:

$8.37

24h Volume:

21,386

Market Cap:

$70.51M

Revenue:

$31.34M

Net Income/Loss:

$-9.52M

P/E Ratio:

28.57

EPS:

0.3

Net Cash Flow:

$1.28M

1W Performance:

+1.42%

1M Performance:

+13.36%

6M Performance:

+69.03%

1Y Performance:

+62.31%

1D Range:

$8.37

$9.1713

52W Range:

$3.67

$9.1713

Cryo Cell International Inc Stock (CCEL) Company Profile

Name

Cryo Cell International Inc

Sector

Healthcare (1223)

Industry

Medical Care Facilities (57)

Phone

813 749 2100

Address

700 Brooker Creek Boulevard, Suite 1800, Oldsmar

Employee

Twitter

Next Earnings Date

2024-04-19

Latest SEC Filings

CCEL's Discussions on Twitter

Cryo Cell International Inc Stock (CCEL) Financials Data

Cryo Cell International Inc (CCEL) Revenue 2024

CCEL reported a revenue (TTM) of $31.34 million for the quarter ending November 30, 2023, a +3.32% rise year-over-year.

Cryo Cell International Inc (CCEL) Net Income 2024

CCEL net income (TTM) was -$9.52 million for the quarter ending November 30, 2023, a -443.57% decrease year-over-year.

Cryo Cell International Inc (CCEL) Cash Flow 2024

CCEL recorded a free cash flow (TTM) of $1.28 million for the quarter ending November 30, 2023, a +114.90% increase year-over-year.

Cryo Cell International Inc (CCEL) Earnings per Share 2024

CCEL earnings per share (TTM) was -$1.14 for the quarter ending November 30, 2023, a -445.45% decline year-over-year.

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.